Login to Your Account

Juno rockets 40 percent after hours
In a deal that both partners cited as "transformative" for their companies and for the field of immunotherapeutics, Celgene Corp. enlisted Juno Therapeutics Inc. as a partner in a broad, global collaboration to leverage T-cell therapies and develop treatments targeting cancer and autoimmune diseases. more »

Our Habitat for All Things Science
Metabolic switch may further tissue regeneration

Scientists made progress toward the goal of mammalian tissue regeneration with the publication of studies showing that mice could be induced to self-repair ear wounds by a drug treatment that increased levels of the transcription factor HIF-1alpha.

"We could convert an animal into a healer," senior author Ellen Heber-Katz, of the Lankenau Institute for Medical Research, told BioWorld Today.